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We examined the effects of exposure to chronic intermittent hypoxia (CIH) on 29 
baroreflex control of renal sympathetic nerve activity (RSNA) and renal excretory responses 30 
to volume expansion (VE) before and after intra-renal TRPV1 blockade by capsaizepine 31 
(CPZ). Male Wistar rats were exposed to 96 cycles of hypoxia per day for 14 days (CIH), or 32 
normoxia. Urine flow and absolute Na+ excretion during VE were less in CIH-exposed rats, 33 
but the progressive decrease in RSNA during VE was preserved. Assessment of the high-34 
pressure baroreflex revealed an increase in the operating and response range of RSNA and 35 
decreased slope in CIH-exposed rats with substantial hypertension (+19mmHg basal mean 36 
arterial pressure, MAP), but not in a second cohort with modest hypertension (+12mmHg). 37 
Intra-renal CPZ caused diuresis, natriuresis and a reduction in MAP in sham and CIH-38 
exposed rats. Following intra-renal CPZ, diuretic and natriuretic responses to VE in CIH-39 
exposed rats were equivalent to sham. TPRV1 expression in the renal pelvic wall was similar 40 
in both experimental groups. Exposure to CIH did not elicit glomerular hypertrophy, renal 41 
inflammation or oxidative stress. We conclude that exposure to CIH: 1) does not impair the 42 
low-pressure baroreflex control of RSNA; 2) has modest effects on the high-pressure 43 
baroreflex control of RSNA, most likely indirectly due to hypertension; 3) can elicit 44 
hypertension in the absence of kidney injury; and 4) impairs diuretic and natriuretic responses 45 
to fluid overload. Our results suggest that exposure to CIH causes renal dysfunction, which 46 
may be relevant to obstructive sleep apnea. 47 
 48 
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ADH Anti-diuretic hormone 
ANP Atrial natriuretic peptide 
AOPP Advanced Oxidation Protein Products 
AUC Area under curve 
CGRP Calcitonin gene- related peptide 
CIH Chronic intermittent hypoxia 
CPZ Capsaizepine 
DBP Diastolic blood pressure 
GFR Glomerular filtration rate 
HR Heart rate 
MAP Mean arterial blood pressure 
NOX NADPH oxidase 
OSA Obstructive sleep apnea 
ROS Reactive oxygen species 
RSNA Renal sympathetic nerve activity 
SBP Systolic blood pressure 
SOD Superoxide dismutase 
SP Substance P 
TRPV1 Transient receptor potential cation 
channel subfamily V member 1 
UFR Urine flow rate 
VE Volume expansion 
IFN-Ɣ Interferon gamma 
IL-1β Interleukin 1 beta 
IL-4 Interleukin 4 
TNF-α Tumor necrosis factor alpha 
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Obstructive sleep apnea (OSA) syndrome is characterized by frequent interruption of 56 
ventilation due to repetitive upper airway obstruction during sleep (35). People with OSA 57 
have a three-fold higher risk of developing hypertension (1). Chronic intermittent hypoxia 58 
(CIH) models the hypoxia and reoxygenation cycles experienced in OSA, due to recurrent 59 
apnea. There is evidence from studies in animal models and humans (25) that exposure to IH 60 
elicits sympatho-excitation and hypertension, revealing that this characteristic feature of the 61 
disorder is adequate to cause autonomic dysfunction, notwithstanding that other features of 62 
OSA, not modelled in CIH, such as hypercapnia and large intra-thoracic sub-atmospheric 63 
pressure swings associated with airway obstruction, could also contribute to cardiovascular 64 
dysfunction in OSA. Animal models of CIH develop sympathetic hyperactivity and diurnal 65 
hypertension (28, 40, 41, 51). Moreover, exposure to CIH evokes detrimental processes in the 66 
kidney such as inflammation, fibrosis, glomerulosclerosis and proteinuria (4, 5, 29, 45), 67 
which are markers for chronic kidney disease.  68 
Fluid homeostasis is mainly regulated by the diuretic and natriuretic function of the 69 
kidney. Fluid overload activates low-pressure cardiopulmonary baroreceptors causing a reflex 70 
suppression of renal sympathetic nerve activity (RSNA) promoting natriuresis and diuresis 71 
(33, 37). Previous studies have revealed blunted low-pressure baroreflex control of RSNA in 72 
response to fluid overload in disease models that involve kidney injury (3, 19, 20). Indeed, 73 
failure of the baroreflex mechanism is associated with long-term elevation of sympathetic 74 
nerve activity, which initiates and/or exacerbates hypertension (15). The influence of 75 
exposure to CIH on the low-pressure baroreflex control of RSNA and kidney function has not 76 
yet been examined. In addition, there is little known about the effects of exposure to CIH on 77 
the high-pressure baroreflex control of RSNA.  78 
The importance of renal innervation in long-term control of blood pressure has 79 
received attention following clinical trials showing that bilateral renal denervation was 80 
associated with a significant reduction of blood pressure in people who are hypertensive with 81 
OSA (16, 43, 49). The involvement of renal nerves in mediating the derangement of 82 
baroreflex control of blood pressure is revealed by renal denervation, which restored the 83 
sensitivity of blunted high- and low-pressure baroreflex control of RSNA in models of 84 
hypertension that involve renal injury (19). In addition, pharmacological inhibition of renal 85 





inflammation, a feature of animal models of CIH (29, 45, 46, 48), was associated with 86 
normalization of baroreflex control of RSNA (3, 21).  87 
Previous studies have shown that selective renal deafferentation was associated with 88 
attenuation of the hypertensive phenotype (9, 12). Afferent renal nerves are densely located 89 
in the renal pelvic wall and to a lesser extent in the cortex, and their activity is mediated by 90 
the neuropeptides, calcitonin gene related peptide (CGRP) and substance P (SP) (13, 30). SP 91 
release is modulated by the activity of other receptors, such as transient receptor potential 92 
vanilloid 1 (TRPV1) channels, localized in the renal pelvic wall. TRPV1 receptors are non-93 
selective cation channels that allow the influx of Na+, Mg2+ and Ca2+ (17). Renal TRPV1 94 
activation is associated with an increase in RSNA and blood pressure in rats (10, 36). In 95 
addition, acute hypoxia increases basal TRPV1 outward current amplitudes, which is 96 
suggested to be due to increased intracellular reactive oxygen species (ROS), that can 97 
increase intracellular Ca2+, with excitatory effects on the afferent reflex (10, 22). Thus, 98 
exposure to CIH might provoke renal oxidative stress and inflammation, sufficient to activate 99 
renal afferent discharge via TRPV1 receptors, eliciting excitatory reno-renal reflexes 100 
contributing to hypertension. 101 
The current study was designed to examine the effects of exposure to CIH on high- 102 
and low-pressure baroreflex control of RSNA and renal excretory responses to fluid overload. 103 
We hypothesized that exposure to CIH increases TRPV1 signalling via renal afferent nerves 104 
modulating baroreflex control of RSNA.  We examined high- and low-pressure baroreflexes 105 
and renal diuretic and natriuretic responses to fluid overload in control and CIH-exposed rats, 106 
before and after intra-renal TRPV1 blockade with capsaizepine (CPZ). 107 
                                                        108 
109 





Materials and Methods 110 
Ethical approval 111 
Eight-week old male Wistar rats were purchased from Envigo (Bicester, UK) and 112 
were housed in our institution’s animal facility under 12-hour light: 12-hour dark cycle with 113 
water and standard chow available ad libitum. All experimental procedures were conducted 114 
under authorization from the Health Products Regulatory Authority [AE19130/P073] in 115 
accordance with European Union directive (2010/63/EU) with prior ethical approval from 116 
University College Cork (AEEC 2018/002). 117 
 118 
Animal model of chronic intermittent hypoxia 119 
Rats were randomly divided into two experimental groups: CIH and sham (control). 120 
Rats assigned to the CIH group were placed in commercial environmental chambers attached 121 
to a computer-controlled gas delivery system (Oxycycler™, Biospherix, NY, USA). Rats in 122 
the CIH group were exposed to recurrent hypoxia cycles, resulting in changes in ambient 123 
oxygen concentration every 5 min within the chamber from 21±2% for 210 sec to a nadir 124 
value of 6±0.5% over 90 sec), for 12 cycles per hour, for 8h during the daytime (lights on), 125 
for 14 consecutive days. Rats of the sham group were housed in the same room and were 126 
exposed to ambient air (~21% O2) for 14 days. On day 15, rats were prepared surgically to 127 
assess high- and low-pressure baroreflexes under anesthesia.  128 
 129 
Surgical protocol 130 
CIH-exposed (n=20) and sham rats (n=23) were anesthetized by intra-peritoneal 131 
injection of a mixture of urethane (416 mg/kg, Sigma-Aldrich, St. Louis, MO, USA), α-132 
chloralose (27 mg/kg, Sigma-Aldrich) and sodium pentobarbital (Euthatal (200 mg/ml), 133 
Merial animal health Ltd, UK, 33 mg/kg). Anesthesia was maintained during surgery using a 134 
maintenance dose of a mixture of urethane (62 mg/kg) and α-chloralose (4 mg/kg), given as 135 
intravenous bolus injection. Animals were placed on a temperature-controlled heating pad to 136 
maintain body temperature at 37°C (Harvard Apparatus, Cambridge, UK). Airway patency 137 
was facilitated by tracheotomy (PE240, Portex, Kent, UK). A cannula (PE25 attached to 138 
PE50) containing heparinized saline (4 U/ml), connected to a fluid-filled pressure transducer 139 





(ADInstruments, Hastings, UK) was inserted into the right femoral artery to measure arterial 140 
blood pressure and heart rate (HR). The pressure transducer was connected to a quad-bridge 141 
amplifier that recorded pulsatile blood pressure using LabChart 7 software (ADInstruments, 142 
Oxford, UK). The right femoral vein was cannulated (PE50) to infuse FITC-inulin (10 143 
mg/kg/hr, TdB consultancy, Uppsala, Sweden) continuously over the duration of the 144 
experiment (32). The urinary bladder was cannulated (PE240) to collect urine samples.  145 
Baseline blood pressure was recorded for 2 minutes ~4-5 minutes after femoral artery 146 
cannulation (before surgical access of the kidney) and compared between the groups, in 147 
essence to confirm the hypertensive phenotype in CIH-exposed rats. In the first of the two 148 
cohort studies, CIH-exposed (n=9) and sham animals (n=10) were then placed on their right 149 
side and the left kidney was exposed by a retroperitoneal flank incision. A cannula (PE10) 150 
was inserted into the rostral part of the left kidney at 3.5-4.5 mm depth, to reach the cortico-151 
medullary region of the kidney (3) and was fixed in place using acrylate glue. This cannula 152 
was connected to a 25 µl micro-syringe (Hamilton, USA) placed on a micro-infusion pump 153 
(KD Scientific, Linton Instruments, Norfolk, UK) to infuse saline or CPZ (5 µg/ml, Sigma-154 
Aldrich, St. Louis, MO, USA) at 17 µl/min. In the second cohort study, CIH-exposed (n=10) 155 
and sham rats (n=13) were placed on their left side to expose the right kidney, which was 156 
cannulated using a similar approach to the first cohort.  157 
In both cohorts, the renal nerve bundle running between the renal artery and vein of 158 
the left kidney was dissected and placed on a bipolar multi-stranded stainless-steel electrode 159 
(Medwire, NY, USA). The nerve bundle was sealed over the recording electrode using 160 
silicone glue (Klasse 4 dental, Augsburg, Germany). RSNA was recorded using a high 161 
impedance head stage attached to an amplifier (NeuroAMP EX®, ADInstruments, UK) 162 
connected to a Power Lab data acquisition system.  163 
 164 
Experimental protocol 165 
The experimental protocol of the first cohort study is described in Figure 1. Baseline 166 
MAP, HR and RSNA were recorded. After intra-renal infusion of saline to the left kidney 167 
high-pressure baroreflex responses were determined. Successive volume expansion (VE) 168 
challenges were performed, first during intra-renal infusion of saline and then during intra-169 
renal infusion of the TRPV1 blocker, CPZ.  170 





The animals were euthanized at the end of the experiment by an overdose of 171 
anaesthetic (mixture of 80 g/kg urethane and 55 mg/kg α-chloralose), given intravenously. 172 
RSNA reaches its maximum level during euthanasia due to the sudden precipitous drop of 173 
blood pressure, before the complete disappearance of RSNA. The maximum RSNA was 174 
determined to allow normalization of baseline RSNA to the maximum. The minimum 175 
electrical activity was measured to determine background noise, which was subtracted from 176 
all recordings.  177 
The second cohort study involved exclusive assessment of the high-pressure 178 
baroreflex response CIH-exposed (n=10) and sham rats (n=10) during two successive phases. 179 
The first phase was after 30 minutes of intra-renal infusion of saline (17 µl/min) and the 180 
second phase was after 30 minutes of intra-renal infusion of CPZ (5 µg/ml at 17 µl/min). In 181 
this cohort of rats, neither VE challenges nor renal function measurements were performed.  182 
 183 
Measurement of Excretory Parameters 184 
Blood samples (P1-P3 samples, Figure 1) of ~400 µl were collected and underwent 185 
centrifugation at 10,956 g for 1 minute. Plasma was stored at -20° for further analysis. To 186 
minimise any change in hematocrit, the blood cells that remained after centrifugation were 187 
suspended in an equivalent volume of saline and returned to the animal via the arterial line. 188 
Blood samples (at P1 and P3, Figure 1) were taken from the femoral artery to measure 189 
sodium concentration using an i-STAT system (Abbott Laboratories, penAbbott Park, IL, 190 
USA). Two urine samples were collected (U1 and U2, Figure 1), during intra-renal infusion 191 
of saline or CPZ. In addition, urine samples were collected during VE (Figure 1). An 192 
additional urine sample was collected during the recovery period i.e. 30 minutes after the end 193 
of the VE trial (Figure 1).  194 
Urine flow (UF), glomerular filtration rate (GFR), and absolute and fractional Na+ 195 
excretion were measured at baseline and during the VE trial. Urine volume was measured 196 
gravimetrically and UF was calculated as: UF = Uv/t; Uv is urine volume, t is time of urine 197 
collection. GFR was measured as a function of FITC-inulin clearance and was calculated 198 
using the formula: GFR= ([Uin]Uv)/[Pin]; [Uin] is urine concentration of FITC-inulin, [Pin] 199 
is plasma concentration of FITC-inulin. FITC-fluorescence was measured in urine and 200 
plasma samples using a fluorometric microplate reader (Wallac victor2 1420 multilabel 201 
counter, Perkin Elmer, MA, USA). Urinary Na+ concentration was measured using flame 202 





photometry (M410, Sherwood Scientific, Cambridge, UK). Plasma Na+ concentration at P2 203 
was determined using flame photometry. However, plasma Na+ concentration (P1 and P3) 204 
was measured immediately upon sample collection using the i-STAT system. Absolute Na+ 205 
excretion was calculated using the formula: [UNa+]. UF; [UNa+] is urinary Na+ 206 
concentration. Fractional Na+ excretion was calculated using the equation: Na+ 207 
clearance/GFR.100% where Na+ clearance = ([UNa+]Uv)/[PNa+]; [PNa+] is plasma Na+ 208 
concentration.  209 
 210 
Atrial natriuretic peptide assay 211 
Atrial natriuretic peptide (ANP) was quantified in plasma samples at baseline (P2) 212 
and during VE (P3) of the saline phase in CIH-exposed (n=7) and sham rats  (n=7) using a 213 
quantitative sandwich ELISA kit (My BioSource, San Diego, CA, USA) as per the 214 
manufacturer’s instructions.  215 
 216 
Tissue preparation 217 
In separate studies, male Wistar rats were exposed for 14 days to normoxia or CIH as 218 
described previously. On day 15, rats were euthanized by an overdose of sodium 219 
pentobarbital (Dolethal (200 mg/ml), Vetoquinol, France, 60 mg/kg), given intra-peritoneally. 220 
The left kidney was collected and halved along its sagittal plane. Each half was cut 221 
transversely into three sections: top, middle (containing the pelvic wall) and bottom. Sections 222 
were preserved at -80⁰C for later use. Immediately after harvesting the left kidney, the left 223 
renal artery and vein were closed by a bulldog clamp. Intra-cardiac puncture via the left 224 
ventricle was performed and warmed heparinized saline (~ 63 U/ml) was infused. The rate of 225 
infusion was 35 ml/min, which was raised gradually to 60 ml/min until 250-300 ml of 226 
heparinized saline was infused into each animal. This was followed by infusion of 4% 227 
paraformaldehyde at an infusion rate of 60 ml/min (Formalin solution, neutral buffered, 10%, 228 
Sigma-Aldrich, St. Louis, MO, USA). The upper and lower poles of the right kidney were 229 
removed, and the remnant kidney was either post-fixed for 24 hours for studies employing 230 
immunofluorescence techniques, or wax-embedded in paraffin. Some kidneys that were 231 
harvested from sham and CIH-exposed rats that underwent surgical procedures were also 232 
perfusion-fixed and wax-embedded in paraffin. In separate CIH-exposed (n=6) and sham rats 233 





(n=6) that were not perfusion-fixed, the right kidneys were excised and after removal of the 234 
upper and lower poles, were directly post-fixed in formalin solution for 24 hours for 235 
subsequent use in studies employing immunofluorescence techniques.   236 
 237 
Biochemical assays 238 
The middle part of the left kidney was homogenized (32) for use in different assays: 239 
Advanced Oxidation Protein Products (AOPP) assay (Cell Biolabs, San Diego, CA), 240 
superoxide dismutase (SOD) and catalase activity assays (Cayman Chemical, Ann Arbor, MI, 241 
USA) and a TRPV1 ELISA assay (Mybiosource, Tokyo, Japan) (sham, n=12; CIH, n=8). The 242 
same homogenization protocol (32) was used to prepare samples for the assessment of 243 
NADPH oxidase (NOX) activity (39) and to determine the concentrations of inflammatory 244 
cytokines in renal tissue (sham, n=11; CIH, n=10), except for the use of a lysis buffer made 245 
of Tris-HCL (20 mM, pH 7.5, Sigma-Aldrich), sodium chloride (150 mM) and 1% Triton-X-246 
100 (Molekula, Dorset, UK) instead of RIPA during homogenization. Absorbances were 247 
measured using a microplate reader (SpectraMax® M3, molecular devices, California, USA).   248 
 249 
Renal inflammatory cytokines 250 
Pro-inflammatory and anti-inflammatory  cytokines (IFN-γ, IL-1β, IL-4, IL-5, IL-6, 251 
keratinocyte chemoattractant/growth related oncogene, IL-10, IL-13, and TNF-α) were 252 
analysed by sandwich immunoassay using a V-plex proinflammatory panel 2 rat kit (Meso 253 
Scale Discovery, Rockville, MD, USA), as per the manufacturer’s instructions. Plates were 254 
analysed using a QuickPlex SQ 120 plate reader (Meso Scale Discovery). IL-1β, TNF-α and 255 
keratinocyte chemoattractant/growth related oncogene were successfully measured. The 256 
concentration of all other cytokines in kidney were below the detection limits of the kit. 257 
 258 
Immunofluorescence  259 
Immunofluorescence for TRPV1 protein expression in the renal pelvic wall was 260 
carried out on 3 CIH-exposed and 3 sham kidneys that were perfusion-fixed and post-fixed, 261 
in addition to 6 CIH-exposed and 5 sham kidneys that were only post-fixed. Frozen, 262 
formalin-fixed kidneys were sectioned to 20 µm sagittal sections using a cryostat (Leica 263 





Biosystems, Wetzlar, Germany). Three sections that contained the renal pelvic wall were 264 
randomly selected from each kidney by systematic random sampling. Non-specific binding 265 
was blocked by incubating sections in 5% goat serum and 1% bovine serum albumin (with 266 
0.5% triton-X) for one hour. Then, sections were incubated with rabbit polyclonal anti-267 
TRPV1 antibody (1:200, ACC-030, Alomone labs) diluted with 5% goat serum, 1% bovine 268 
serum albumin and 0.5% triton-X for two hours at 37°C. Sections were incubated with goat 269 
anti-rabbit FITC secondary antibody (1:100, Sigma-Aldrich, St. Louis, MO, USA) for two 270 
hours at room temperature. Sections were covered with anti-fade mounting medium 271 
(Vectashield, Vector laboratories, Burlingame, CA, USA). 272 
Images were captured using a laser scanning confocal microscope (Olympus FV1000-273 
IX71, Tokyo, Japan) provided with filters for FITC and DAPI. Sections were initially 274 
visualized using 20X magnification under the DAPI filter and three regions of the pelvic wall 275 
were randomly selected from each section. After selection, the FITC filter was switched on to 276 
capture images. Positive staining was detected in the uroepithelial layer and submucosa/ 277 
muscularis propria layers of the pelvic wall. Images were transferred to black and white 278 
images and the threshold was adjusted to highlight the area occupied by fluorescent labeling 279 
of TRPV1 using Image J software. Threshold area was calculated and normalized to the total 280 
area of the uroepithelium within the image to quantify the expression of TPRV1 in that 281 
region. Similarly, threshold area in the submucosa and muscularis propria layers were 282 
calculated and normalized to the total area identified in the image.  283 
  284 
Renal histopathological staining 285 
Kidneys were taken from CIH-exposed (n=8) and sham rats (n=8) that underwent 286 
surgical procedures as well as from rats euthanized following exposure to gasses without 287 
undergoing surgery. Paraffin blocks were cut to 10 µm tissue sections using a rotary 288 
microtome (Leica RM2135, Germany). Two sections were randomly selected by random 289 
number generator each from the upper, middle and bottom parts of the paraffin block (a total 290 
of 6 sections from each kidney block). Sections were de-waxed using Neo-Clear® xylene 291 
substitute (Merck, Darmstadt, Germany) and washed with down-graded levels of ethanol. 292 
Tissue sections were then stained in hematoxylin (Hematoxylin Solution, Harris Modified, 293 
Sigma-Aldrich, St. Louis, MO, USA) and eosin (Surgipath Europe LTD, Cambridgeshire, 294 
UK or with Sirius red stain (0.1% Direct red 80, Sigma-Aldrich, India). Sections were cleared 295 





in Neo-Clear® xylene substitute, and mounted with DPX mounting medium (Sigma-Aldrich, 296 
St. Louis, MO, USA).  297 
Hematoxylin and Eosin staining was used to examine total glomerular tuft area. A 298 
virtual grid comprised of 91 squares was created to enable random sampling of cortical areas 299 
of each kidney section. Selected squares were magnified using a 40X magnification lens to 300 
image selected glomeruli (only when the juxtaglomerular apparatus was evident). As some 301 
squares did not include any glomeruli and/or the juxtaglomerular apparatus was not visible in 302 
some glomeruli, other squares were randomly chosen so that a total of 3 glomeruli per kidney 303 
section were analyzed. As 6 sections were randomly selected from each animal, a total of 18 304 
glomeruli per animal were chosen to measure glomerular tuft area. Images were taken using a 305 
40X magnification lens (Olympus inverted BX53F microscope, Tokyo, Japan) and tuft area 306 
was measured using ImageJ software. 307 
Sirius red stain was used to semi-quantify areas occupied by collagen in the cortex 308 
and outer medulla. A virtual grid with 25 squares was used to enable random selection of 309 
cortical and medullary areas. Selected squares were magnified using a 20X magnification 310 
lens to capture images. Three cortical areas and two outer medullary areas per kidney section 311 
were randomly chosen. As 6 sections were stained from each animal, a total of 18 cortical 312 
areas and 12 areas from the outer medulla were selected for analysis. Glomeruli and 313 
perivascular fibres were omitted from images before analysis. The fibrotic area of each image 314 
was normalized to the total area of the captured image to generate the % fibrotic area (Figure 315 
2).  316 
Statistical analysis 317 
Data in tables and within text are presented as mean ± SD. Line figures are shown as 318 
mean ± SE. Baseline MAP, HR and RSNA were compared between groups using 319 
independent sample t-tests. Baseline RSNA was expressed as absolute values (µV.s) and also 320 
was normalized to the maximum RSNA value recorded during euthanasia, expressed as 321 
RSNA (% of max). Values were compared between groups using repeated-measures two-way 322 
ANOVA.  323 
Baseline values for UF, GFR, and absolute and fractional Na+ excretion were 324 
compared using repeated-measures two-way ANOVA. RSNA sympatho-inhibitory response 325 
to VE was expressed as % of baseline (baseline=100%) and as RSNA (% of max). The 326 
change in functional parameters and the decrease in RSNA in response to VE were analysed 327 





using repeated-measures two-way ANOVA followed by a Bonferroni post hoc test. The area 328 
under the curve (AUC)  of RSNA (% of baseline), RSNA (% of max), and each functional 329 
parameter was compared between groups and between the saline VE phase and CPZ VE 330 
phase using independent sample t-test and paired t-test, with significance taken at P˂0.0125,  331 
accounting for multiple comparisons. 332 
High pressure baroreflex function curves were fitted according to a logistic sigmoidal 333 
function equation that shows the relationship between MAP and RSNA or HR 334 
[y=A1/(1+exp(A2(x-A3)))+A4] where y is the RSNA or HR; A1, response range over which 335 
baroreceptors operate; A2, gain coefficient; A3, mid-point blood pressure; A4, minimum 336 
response of RSNA or HR. Parameters were compared between the sham and CIH-exposed 337 
groups using independent sample t-test and significance was taken at P<0.05.Baroreflex gain 338 
curve parameters during the first (saline) and second (CPZ) phase were compared using 339 
paired t-tests. Significance was taken at P<0.0125, accounting for multiple comparisons. 340 
Data from biochemical assays, histology and immunofluorescence from CIH-exposed 341 
and sham tissues were analysed using independent sample t-tests or Mann-Whitney tests, and 342 
significance was taken at P<0.05. All statistical analyses were performed using SPSS 343 
software (SPSS Statistics for Windows, v25.0. IBM corp., NY, USA). All graphs were 344 










Baseline MAP, HR, RSNA and renal excretory parameters 350 
 A representative recording of baseline parameters is shown in Figure 3. In the first 351 
cohort study, MAP was greater in CIH-exposed rats compared with sham rats (Table 1). 352 
Baseline RSNA was greater in CIH-exposed rats compared with sham rats (RSNA (% of 353 
max), 36±15% vs. 17±7%, p=0.006). MAP was greater in CIH-exposed rats of the second 354 
cohort compared with sham rats, but to a lesser extent compared with rats of the first cohort 355 
study (Table 1 and Supplementary Table 1 https://figshare.com/s/7bc496e361e5e47043d7). 356 
HR was similar in CIH-exposed and sham rats of both cohorts. Baseline renal function data 357 
are shown in Supplementary Table 2 (https://figshare.com/s/7796b802afe6c02d54f0). 358 
Exposure to CIH had no significant effect on any of the basal renal excretory parameters. 359 
 360 
Cardiovascular responses to VE  361 
Baseline ANP concentration in plasma prior to VE challenge was not significantly 362 
different between CIH-exposed and sham rats (CIH vs. sham; 157±17 vs. 167±36 pg/ml). 363 
MAP and HR data during each VE trial are shown in Figure 4a and 4b. During the last 2 364 
minutes of each VE trial, MAP was not significantly different from respective baseline values 365 
recorded prior to VE (Table 2). HR was significantly elevated during the last 2 minutes of 366 
each of the VE trials, both in CIH-exposed and sham rats (Table 2). 367 
 368 
Renal excretory responses to VE  369 
VE in CIH-exposed and sham rats resulted in significant increases in GFR, UF and 370 
Na+ excretion (Figure 4d-g). The response pattern and magnitude of GFR and fractional Na+ 371 
excretion during VE were similar in sham and CIH-exposed rats. Diuresis in response to VE 372 
was of significantly lesser magnitude in CIH-exposed rats compared with sham rats after 25 373 
and 30 minutes (Figure 4d). Similarly, absolute Na+ excretion was significantly less in CIH-374 
exposed rats after 30 minutes of VE (Figure 4f). Analysis of AUC, reflecting the temporal 375 
cumulative response to VE, revealed that UF was significantly less in CIH-exposed rats 376 
compared with sham rats (Figure 4d, f). 377 
 378 






RSNA response to VE  380 
VE caused a progressive significant decrease in RSNA, which reached its maximum 381 
decline after 28-30 minutes (Figure 4c). The decrease in RSNA during VE with concomitant 382 
intra-renal infusion of saline was not significantly different in CIH-exposed and sham rats 383 
(Figure 4c). 384 
 385 
High-pressure baroreflex  386 
Representative recordings from high-pressure baroreflex trials are shown in Figure 5a. 387 
The slope of the RSNA baroreflex function curve of CIH-exposed rats was less than that of 388 
sham rats (A2 parameter: Figure 6a). This was related to a significant elevation in response 389 
range (A1 parameter) and operating range (Table 3) in CIH-exposed rats compared with 390 
sham rats. A rightward shift in the pressure at which the baroreceptors operate (A3 391 
parameter), by ~20 mmHg (p=0.005), in CIH-exposed rats was observed (Figure 6 and Table 392 
3).. Conversely, data from the second cohort study (with a more modest increase in MAP in 393 
CIH-exposed rats) revealed no difference in any of the parameters between CIH-exposed and 394 
sham rats (Figure 6).  395 
These apparently conflicting results obtained from the two cohorts are likely 396 
explained by the moderate correlation (Figure 7) that we found between baseline blood 397 
pressure and the slope (A2, R2=0.386, p=0.017) and mid-point pressure (A3, R2= 0.639, 398 
p<0.0001) of RSNA baroreflex function curves, combining all rats in both cohorts.  399 
Parameters of the baroreflex control of HR were not significantly different between CIH-400 
exposed and sham rats in either of the two cohort studies (Table 3). 401 
 402 
Baseline MAP, HR, RSNA and renal excretory parameters during intra-renal TRPV1 403 
blockade 404 
Intra-renal infusion of saline had no significant effect on blood pressure, HR and 405 
RSNA in either cohort (Table 2 and Supplementary Table 1 406 
https://figshare.com/s/7bc496e361e5e47043d7). In contrast, MAP was lower during intra-407 
renal infusion of CPZ both in CIH-exposed and sham rats (of both cohorts), compared with 408 





respective baseline values measured prior to CPZ infusion, whereas RSNA and HR were 409 
unchanged (Table 2 and Supplementary Table 1 410 
https://figshare.com/s/7bc496e361e5e47043d7).  During intra-renal infusion of CPZ there 411 
was a significant diuresis and natriuresis, both in CIH-exposed and sham rats compared with 412 
respective values measured prior to CPZ infusion (Supplementary Table 2 413 
https://figshare.com/s/7796b802afe6c02d54f0).  414 
 415 
Renal excretory responses to VE during intra-renal TRPV1 blockade 416 
During intra-renal infusion of CPZ, significant increases in UF and absolute Na+ 417 
excretion in response to VE were observed in CIH-exposed and sham rats, with no significant 418 
difference between the experimental groups (Figure 4).  419 
 420 
Low- and high-pressure baroreflex control during intra-renal TRPV1 blockade 421 
During intra-renal infusion of CPZ, the decrease in RSNA (% of max) in response to 422 
VE was equivalent in CIH-exposed and sham rats (Figure 4c). However, an apparent 423 
potentiation of the RSNA sympatho-inhibitory response to VE was observed in both groups 424 
when RSNA (% of baseline) was considered (Supplementary Figure S1, 425 
https://figshare.com/s/9659e62049b971e25ab7). Intra-renal CPZ did not significantly affect 426 
high-pressure baroreflex of RSNA or HR in CIH-exposed and sham rats of cohort 2 427 
(Supplementary Table 3 https://figshare.com/s/870e5f260f49995a4d8d, and Figure 6c and 428 
6d). 429 
 430 
TRPV1 immunofluorescence in renal tissue 431 
TRPV1 channels are mainly expressed in the fibres located between the muscular 432 
layer and the uroepithelium of the renal pelvic wall (Figure 8). Positive staining was also 433 
expressed in the uroepithelium (Figure 8). TRPV1 fluorescence occupied 5.1±1.0% of the 434 
area of the muscularis propria of the pelvic wall of CIH-exposed rats, which was equivalent 435 
to sham rats (6.4±1.9%, Figure 8f). TRPV1 expression in the uroepithelium was equivalent 436 
between CIH-exposed and sham rats (3.7±0.9% vs. 3.9±1.1%). TRPV1 protein concentration 437 





in kidney tissue (Figure 8f, bottom) was not significantly different between CIH-exposed and 438 
sham rats.  439 
 440 
Renal histopathological assessment 441 
The average glomerular tuft area was equivalent in CIH-exposed and sham rats 442 
(Figure 9). A slightly greater degree of fibrosis was observed in the cortex of CIH-exposed 443 
kidneys compared with sham kidneys (Figure 9b and d). In contrast, there was no significant 444 
difference in collagen expression in the outer medulla between CIH-exposed and sham 445 
kidneys (Figure 9c and d).   446 
 447 
Renal oxidative stress, inflammation and protein oxidation 448 
The activity of NOX, SOD and catalase enzymes was measured in whole kidney 449 
tissue and there was no significant change in the activity of these enzymes after exposure to 450 
CIH. There was no significant difference in NOX, SOD and catalase enzyme activities 451 
between CIH-exposed and sham rats (Table 4). Furthermore, there was no evidence of greater 452 
protein oxidation in the kidneys of CIH-exposed rats (Table 4). Cytokine concentrations (IL-453 
1β, keratinocyte chemoattractant/growth related oncogene and TNF-α) were not significantly 454 
















This study provides several novel findings: 1) In CIH-exposed rats, diuretic and natriuretic 466 
responses to VE were impaired, notwithstanding that the sympatho-inhibitory response of 467 
RSNA to fluid overload was preserved; 2) the high-pressure baroreflex was modestly affected 468 
in CIH-exposed rats, an outcome that was related to the magnitude of CIH-induced 469 
hypertension, suggesting an indirect effect of exposure to CIH; 3) CIH-induced hypertension 470 
can manifest in the absence of renal injury. 471 
VE produced reductions in RSNA similar to the findings of previous studies (8, 19). 472 
Exposure to CIH, sufficient to cause hypertension, did not adversely affect the sympatho-473 
inhibitory response of RSNA to VE. This revealed that altered low-pressure baroreflex 474 
control of RSNA did not contribute to CIH-induced hypertension.  475 
Basal renal function was equivalent in sham and CIH-exposed rats. However, the 476 
renal excretory response to VE in CIH-exposed rats was blunted with resultant sodium and 477 
fluid retention. These findings suggest that compensatory mechanisms in the kidney ensured 478 
maintenance of normal basal kidney function in the face of CIH-related stress and 479 
sympathetic over-activity. Dysfunction was revealed however, during VE challenge, with 480 
evidence of blunted diuretic and natriuretic responses, which appear independent of neural 481 
control of the kidney. Similarly, in streptozotocin-induced diabetic rats, basal diuresis and 482 
natriuresis were equivalent to non-diabetic rats, but excretory responses were impaired during 483 
VE (44). The underlying mechanisms that contribute to impairment of VE-dependent 484 
excretory responses are multifactorial and do not depend solely on changes in RSNA. Such 485 
mechanisms include alterations in renin-angiotensin system (RAAS) activity, renal perfusion 486 
pressure, and GFR. Thus, our finding of blunted sodium and fluid excretion during VE, 487 
despite preserved reflex reduction in RSNA, highlights that other mechanisms contribute to 488 
diuretic and natriuretic responses to VE and reveals that one or more of these mechanisms are 489 
perturbed by exposure to CIH.  490 
Impaired cardiac baroreflex function was previously reported in people with OSA and 491 
in rats exposed to CIH (24, 38). Accordingly, we hypothesized that exposure to CIH disrupts 492 
the high-pressure baroreflex control of RSNA (3, 18, 20). CIH-exposed rats of the first cohort 493 
showed a significant shift in mid-point blood pressure by almost 20 mmHg, which was 494 
associated with an increase in the operating range of the RSNA baroreflex. Moreover, a 495 





marked increase in response range (A1 parameter) of the RSNA baroreflex was evident in 496 
CIH-exposed rats. Elevation in the operating and response range of RSNA resulted in a 497 
decrease in the slope of the baroreflex (A2 parameter).  These changes were concomitant 498 
with a substantial hypertensive phenotype (Table 1). Conversely, CIH-exposed rats of the 499 
second cohort with modest hypertension displayed baroreflex responsiveness that was 500 
equivalent to the respective sham group. Interestingly, a significant correlation between basal 501 
MAP and the baroreflex slope (A2) and between MAP and mid-point pressure (A3) was 502 
evident (Figure 7). This indicates that resetting of RSNA baroreflex and apparent decreased 503 
slope of the curve  is associated with elevated blood pressure. It is likely that  baroreflex 504 
adjustments following exposure to CIH in this study and marked attenuation of baroreflex 505 
function observed in severe CIH protocols, are secondary to the elaboration of hypertension 506 
following exposure to CIH, as the second cohort of rats were hypertensive (modest compared 507 
with cohort 1), but displayed no changes in baroreflex parameters revealing that the latter is 508 
not obligatory for the manifestation of CIH-induced hypertension.  509 
The baroreflex control of HR was unchanged in CIH-exposed rats in agreement with 510 
previous studies utilizing 5, 7 and 10 days of exposure to CIH (24, 47, 50). Lai et al (24) 511 
analysed day-to-day arterial blood pressure and baroreflex sensitivity of the heart in 512 
conscious rats. MAP was higher by 15 mmHg after 5 days of exposure to CIH with no 513 
alteration in baroreflex function, followed by a decline in baroreflex sensitivity starting 10 514 
days after the onset of exposure to CIH (24). Indeed, long-term exposure to CIH was 515 
associated with decreased cardiac baroreflex gain (11, 14, 27). 516 
In renal injury, there is activation of renal pelvic chemoreceptors causing activation of 517 
afferent renal nerves, sympatho-excitation and hypertension (7, 23, 31, 34). In renal failure 518 
and high fat-induced obesity models, impairment of high- and low-pressure baroreflex 519 
function was linked to increased renal afferent nerve activity (3, 20). Therefore, renal 520 
denervation and/or suppression of renal inflammation is associated with restoration of the 521 
baroreflex control of RSNA (19, 21). Similarly, in some animal models of CIH, increases in 522 
systemic and renal inflammatory biomarkers and ROS have been reported together with 523 
impaired baroreflex control of HR (11, 24, 47). Afferent renal nerve fibres are abundant in 524 
the renal pelvic wall (23). A subset of these afferent nerves contains TRPV1, which is co-525 
localized with neurotransmitters such as SP (17). In rats, cortico-medullary infusion of the 526 
TRPV1 agonist capsaicin induces an excitatory reno-renal reflex and an increase in blood 527 
pressure (36). It is also known that acute hypoxia increases the tonic activity of TRPV1 528 





receptors. Hypoxia-induced activation of TRPV1 was suppressed using CPZ and Tiron, a 529 
membrane permeable ROS scavenger (22). Moreover, in vitro studies showed that TRPV1 530 
activation decreases cell viability and induces apoptosis (42). This effect is mediated by an 531 
increase in intracellular calcium influx followed by ROS production, which causes 532 
mitochondrial depolarization and DNA fragmentation (42).  533 
CPZ, at a similar dose to that used in the present study, was utilized in previous 534 
studies to block TRPV1 resulting in marked changes in RSNA (26). The infusion of CPZ 535 
over 30 minutes in the present study diffused into the pelvic wall where renal afferent nerves 536 
are located. This was confirmed histologically by observing the location of lissamine green 537 
stain infused for 30 minutes (not shown). Intra-renal infusion of CPZ caused a significant 538 
diuresis and natriuresis accompanied by significant reduction in MAP, but without an 539 
attendant decrease in RSNA. In addition, the renal sympatho-inhibitory response to VE after 540 
CPZ administration was unaffected, both in CIH-exposed and sham rats.  Nevertheless, 541 
following intra-renal infusion of CPZ, diuretic and natriuretic responses to VE were 542 
equivalent in CIH-exposed and sham rats, which suggests a potential role of renal TRPV1 543 
receptors in CIH-induced impairment of renal excretory function, although we cannot 544 
exclude the possibility that the intra-renal CPZ-induced diuresis and natriuresis per se (which 545 
was independent of RSNA) may have contributed to the recovery of renal excretory 546 
responses to VE in CIH-exposed rats, masking the original mechanism contributing to 547 
impaired renal excretory function. Therefore, our results should be viewed as preliminary and 548 
the molecular mechanisms contributing to CIH-induced impairment in renal excretory 549 
function requires further study.  550 
Of interest, there was no difference between CIH-exposed and sham rats in TRPV1 551 
expression in the renal pelvic wall. Histological analysis in the CIH-exposed rats showed 552 
modest cortical fibrosis, which may relate to decreased cortical oxygen tension and reduced 553 
renal blood flow in CIH-exposed rats, which was previously reported (32). Interestingly, 554 
neither inflammation nor altered pro- or anti-oxidant enzymatic activity was evident in CIH-555 
exposed kidneys. Moreover, inflammatory cytokine concentrations were not different 556 
between experimental groups. Variable renal outcomes at the molecular level in animal 557 
models of CIH are likely related to differences in the pattern, duration and intensity of CIH, 558 
as recently reviewed (6). Glomerular hypertrophy and/or inflammation was reported in other 559 
studies (45), but were not observed in this study, suggesting that these changes, when they 560 





occur, are more likely to be secondary to hypertension, rather than a direct effect of exposure 561 
to CIH, although they may also arise due to synergistic effects of hypertension and hypoxia.  562 
This study has several limitations. Data were collected from anesthetized rat 563 
preparations. As such, cardiovascular, renal, and autonomic nervous system function were 564 
altered compared with the conscious state. It will be important to determine if exposure to 565 
CIH adversely affects renal excretory function in conscious animals. Intra-renal CPZ 566 
administration was unilateral, which might not reflect the full biological effect of TRPV1 567 
antagonism. Unilateral infusion of drugs has been used effectively in other studies of 568 
baroreflex function (2, 3). In the present study, unilateral CPZ produced renal and 569 
cardiovascular effects, nevertheless the effects of bilateral TPRV1 inhibition is worthy of 570 
further investigation. For logistical reasons, high-pressure baroreflex function was not 571 
assessed after intra-renal CPZ in rats of cohort 1, where baroreflex alterations were 572 
subsequently revealed. The effect of intra-renal CPZ was assessed in rats of cohort 2, but 573 
high-pressure baroreflex control of RSNA was preserved in these rats with modest 574 
hypertension. Therefore, we cannot discount a possible role for TRPV1 signalling in 575 
modulating high-pressure baroreflex control of RSNA in CIH-exposed rats and this warrants 576 
further attention. Our study design involved the assessment of RSNA and renal excretory 577 
responses to VE in successive challenges, before and after intra-renal TRPV1 blockade. We 578 
acknowledge that restoration of renal excretory responses to VE in CIH-exposed rats, which 579 
was attributed to blockade of TRPV1 receptors, might relate to the performance of a second 580 
VE trial per se, independent of antagonism. Moreover, renal excretory responses to the 581 
second VE challenge should be viewed in the context of the profound diuresis and natriuresis 582 
caused by intra-renal CPZ. Our data on GFR during VE should be viewed cautiously given 583 
that measurements were not taken in steady-state conditions and blood sampling was limited 584 
as we did not wish to interfere with MAP, and hence reflex control of RSNA, during VE 585 
challenges. 586 
In summary, a relatively modest paradigm of exposure to CIH was sufficient to 587 
induce hypertension, without evidence of renal inflammation and/or oxidative stress. 588 
Exposure to CIH blunted sodium and fluid excretion in response to VE with preserved 589 
suppression of RSNA. Exposure to CIH induced modest changes in  high-pressure baroreflex 590 
control of RSNA, which was dependent on the magnitude of blood pressure elevation in CIH-591 
exposed rats suggesting that modulation of high-pressure baroreflex control of RSNA in this 592 
model is a consequence of hypertension, but may in turn proceed to a pathological level and 593 





contribute to disease progression. Our results suggest that exposure to CIH causes renal 594 
dysfunction, which may be relevant to obstructive sleep apnea. 595 
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Figure legends: 761 
Figure 1: A schematic representation of the experimental protocol. In sham and 762 
CIH-exposed rats of cohort 1, following a 1 hour stabilization period, baseline cardiovascular 763 
and RSNA were determined. After intra-renal infusion of saline to the left kidney for 30 764 
minutes, phenylephrine (PE, 50 µg/ml, 0.2 ml) and sodium nitroprusside (SNP, 50 µg/ml, 0.2 765 
ml) were infused intravenously to elicit high-pressure baroreflex responses. The first volume 766 
expansion (VE) trial (saline phase) was then performed, which was followed by a 90-minute 767 
recovery period. Then, intra-renal infusion of CPZ was initiated for 30 minutes into the left 768 
kidney and a second VE trial was performed. Two urine samples (U1 and U2) were collected 769 
during baseline before each VE trial. The “Urine collection” phase represents the collection 770 
of a urine sample 10 minutes after the start of the VE trial followed by subsequent collection 771 
of urine samples every 5 minutes until the end of the VE challenge. Arterial blood was 772 
sampled for plasma (P1 and P2). Each VE trial was accompanied by infusion of inulin (FITC-773 
inulin in saline, 10 mg/kg) for 30 minutes via the femoral vein at 0.25 ml/min/100g body 774 
weight using a syringe pump (Graseby syringe pump 8100, Dublin, Ireland). Each VE trial 775 
period was followed by 30 minutes of recovery during which infusion of saline through the 776 
intravenous line was stopped, but with continuous intra-renal infusion of saline or CPZ. P, 777 
plasma sample; VE, volume expansion; I.R., intra-renal; CPZ, capsaizepine; PE, 778 
phenylephrine; SNP, sodium nitroprusside.  779 
 780 
Figure 2: Assessment of renal fibrosis. A virtual grid was used for the random selection of 781 
kidney regions. Sirius red stained images were converted to grey scale and a colour threshold 782 
function was used to highlight collagen labelling in red.  783 
 784 





Figure 3: Original recordings of cardiovascular parameters and RSNA in an 785 
anesthetised rat. Representative original recordings of baseline arterial pressure (AP), heart 786 
rate (HR) which was derived from the AP recording, and raw and integrated RSNA (Int. 787 
RSNA) recordings from a sham rat.  788 
 789 
Figure 4: Cardiovascular, RSNA and renal excretory responses to VE. In sham (n=8) and 790 
CIH-exposed rats (n=9), MAP, HR, RSNA, UF, GFR, absolute and fractional Na+ excretion 791 
responses to VE challenges were determined. In the left-hand panels, the time course of 792 
responses to and recovery from VE during intra-renal infusion of saline or CPZ (TRPV1 793 
blocker) are shown. Data (mean±SE) were averaged over each 2-minute period during VE 794 
trials. Two-way ANOVA (time x exposure) was used to statistically compare the data. # 795 
p<0.05 for time; Φ p<0.05 for time points significantly different from respective baseline 796 
(post-hoc analysis); Ψ p<0.05 for exposure; * p<0.05 compared with corresponding time 797 
point in sham rats. In the right-hand panels, area under the curve (AUC) analysis for the 798 
respective responses is shown (expressed in arbitrary units, AU), calculated using the 799 
trapezoidal rule, by the summation of the VE period. Data are shown as individual data points 800 
for each rat, with box and whiskers plots representing the interquartile range and maximum 801 
and minimum values. Data were compared with independent t-tests. Significance was taken 802 
at p<0.0125, accounting for multiple comparisons. MAP, mean arterial pressure; RSNA, 803 
renal sympathetic nerve activity; UF, Urine flow; GFR, glomerular filtration rate; MAP, 804 
mean arterial blood pressure; HR, heart rate; CPZ, capsaizepine. 805 
 806 
Figure 5: Original recordings illustrating high- and low-pressure baroreflex control of 807 
RSNA in anesthetised rats. Representative original recordings of arterial blood pressure, 808 
raw and integrated RSNA responsiveness to blood pressure manipulations evoking the high-809 
pressure baroreflex (a) and VE evoking the low-pressure baroreflex (b). Recordings are 810 
shown for representative sham and CIH-exposed rats showing responses during intra-renal 811 
infusion of saline and intra-renal infusion of CPZ, (TRPV1 blocker). AP, arterial blood 812 
pressure; RSNA, renal sympathetic nerve activity; Int. RSNA, integrated RSNA; VE, volume 813 
expansion; CPZ, capsaizepine. 814 
 815 





Figure 6: High-pressure baroreflex control of RSNA. Data (mean±SE) are shown for 816 
RSNA (% of baseline) as a function of arterial blood pressure in sham and CIH-exposed rats 817 
of the first (a; sham, n=10; CIH, n=8) and second cohort (b; sham, n=10; CIH, n=10). In 818 
graphs (c) and (d), data (mean±SE) are shown for RSNA (% of baseline) as a function of 819 
arterial blood pressure during intra-renal infusion of saline and CPZ (TRPV1 blocker) of 820 
sham (c) and CIH-exposed rats (d) of the second cohort. Data for baroreflex parameters are 821 
shown in table 3 and supplementary table 3 (https://figshare.com/s/870e5f260f49995a4d8d). 822 
RSNA, renal sympathetic nerve activity; BP, blood pressure. 823 
 824 
Figure 7: Correlations between baseline MAP and baroreflex parameters. The 825 
relationship between mean arterial blood pressure and the baroreflex parameters, A3 and A2, 826 
are shown for all sham (n=20) and CIH-exposed rats (n=18). Linear regression analysis was 827 
performed. Significance was taken at P<0.05. MAP, mean arterial blood pressure; A3, 828 
midpoint pressure of the response; A2, gain coefficient.  829 
 830 
Figure 8: TRPV1 immunofluorescence in the renal pelvic wall. Immunofluorescence 831 
labeling of renal pelvic wall showing TRPV1-positive labeling within the muscularis propria 832 
(white arrows) and uroepithelium layer (red arrows). (a) is a representative image from a 833 
sham kidney and (b) is a representative image from a CIH-exposed kidney. Negative controls 834 
demonstrate specificity of the antibodies used in the study (c, primary antibody omitted; e, 835 
secondary antibody omitted); Blue labelling of nuclei by Hoescht. (d) Immunofluorescence 836 
labeling of TRPV1 channels in neuronal cell bodies of lumbar dorsal root ganglia as a 837 
positive control. Scale bar 50 µm. Data for TRPV1-positive staining (% of total area) in sham 838 
(n=8) and CIH-exposed rats (n=9) are shown as individual data points for each rat, and box 839 
and whiskers plots representing the interquartile range and maximum and minimum values (f, 840 
top). Data for TRPV1 protein concentration of kidney tissue homogenate in sham (n=12) and 841 
CIH-exposed rats (n=8) are shown as individual data points for each rat, with box and 842 
whiskers plots representing the interquartile range and maximum and minimum values (f, 843 
bottom). Data were compared with independent t-tests. Significance was taken at p<0.05.  844 
 845 





Figure 9: Renal histology. Representative images from a sham and CIH-exposed rat are 846 
shown. (a) shows hematoxylin and eosin staining; (b) shows Sirius red staining of renal 847 
cortex; (c) shows Sirius red staining of renal outer medulla. Scale bar 50 µm. Data for 848 
glomerular tuft area and percentage fibrotic area are presented in (d) as individual data points 849 
for each rat, with box and whiskers plots representing the interquartile range and maximum 850 
and minimum values. Data from sham (n=8) and CIH-exposed rats (n=8) were compared 851 
using independent t-tests. Significance was taken at p<0.05. 852 
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Data are presented as mean±SD and were collected from the first (sham, n=10; CIH-7 
exposed, n=9) and second cohorts of animals (sham, n=13; CIH, n=10). Baseline 8 
cardiovascular parameters were recorded for 2 minutes ~4-5 minutes after arterial 9 
cannulation i.e. before retroperitoneal incisions were performed to expose the kidneys. 10 
Cardiovascular parameters and RSNA were also recorded for 2 minutes after the 11 
stabilization period, 1 hour following renal surgical instrumentation. Parameters were 12 
analysed using independent samples t-test or Mann-Whitney test. * p<0.05 between 13 
exposure groups. CIH, chronic intermittent hypoxia; MAP, mean arterial blood pressure; 14 
SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; RSNA (% of 15 
max), renal sympathetic nerve activity normalized to maximum activity recorded during 16 
baroreflex activation during euthanasia. 17 
 18 
 19 
Parameter Sham CIH p-value Sham      CIH p-value 
After arterial cannulation (before renal surgical instrumentation) 
First cohort Second cohort 
MAP (mmHg) 124±13 143±7* 0.001 115±11 127±9* 0.014 
SBP (mmHg) 143±17 163±11* 0.008 137±13 144±12 0.154 
DBP (mmHg) 114±12 133±5* <0.0001 104±11 118±10* 0.005 
HR (beats/min) 432±28 461±39 0.083 411±29 425±41 0.355 
After stabilization (after renal surgical instrumentation) 
MAP (mmHg) 84±9 97±11* 0.028    103±12 107±18 0.565 
SBP (mmHg) 116±14 125±15 0.262 134±15 132±22 0.871 
DBP (mmHg) 69±8 82±11* 0.043 88±13 94±19 0.365 
HR (beats/min) 400±52 445±47 0.084 436±19 450±34 0.204 
RSNA (% of max) 17±7 36±15* 0.006 24±10 32±18 0.387 
RSNA (uV.s) 0.66±0.30 1.34±0.73 0.231 1.39±0.84 1.67±0.65 0.878 
Maximum 
RSNA ( uV .s) 
4.70±2.03 4.03±2.18 0.349 7.04±5.29 6.60±3.54 1.000 






Table 2. MAP, HR and RSNA before and during VE challenges in sham and CIH-21 
exposed rats.  22 
 23 














(% of max) 
RSNA 
(uV.s) 
                    Before intra-renal infusion of saline                   Before intra-renal infusion of CPZ  
Sham 90±9 409±35 15±5 0.71±0.34 94±11 430± 41 18±6 0.87±0.43 
CIH 99±10 444±49 32±18ɸ 1.19±0.82 98±11 448± 42 23±6 0.95±0.72 
                  After intra-renal saline (before VE)                      After intra-renal CPZ (before VE)  
Sham 90±8 408±49 18±8 0.86±0.50 83±5# 412±45 18±6 0.86±0.41 
CIH 90±4 428±46 30±14ɸ 1.14±0.78 90±5# 431±46 22±8 0.94±0.74 
                               Last two minutes of VE                                       Last two minutes of VE  
Sham 92±15 451±35* 15±6*  76±10 443±33* 12±6*  
CIH 91±9 458±31* 18±5*  90±9 450±25* 11±8*  
 2X2 ANOVA (before vs. after intra-renal saline/CPZ)  
Exposure P=0.075 P=0.131 P=0.035 P=0.180 P=0.225 P=0.165 P=0.158 P=0.567 
Time P=0.102 P=0.084 P=0.894 P=0.330 P=0.024 P=0.100 P=0.722 P=0.396 
Exposure 
X time 
P=0.065 P=0.007 P=0.044 P=0.137 P=0.502 P=0.748 P=0.975 P=0.838 
 2X2 ANOVA (after intra-renal saline/CPZ vs. last two minutes of VE)  
Exposure P=0.516 P=0.404 P=0.077  P=0.045 P=0.205 P=0.581  
Time P=0.072 P<0.001 P=0.01  P=0.168 P=0.002 P=0.001  
Exposure 
X time 
P=0.786 P=0.182 P=0.115  P=0.073 P=0.218 P=0.252  
 24 
Data were collected from sham (n=8) and CIH-exposed rats (n=9) of the first cohort. Data 25 
are expressed as mean±SD. Baseline values over a 2-minute period were averaged before 26 
and after the infusion of saline or CPZ and were analysed using repeated-measures two-27 
way ANOVA. The last two minutes of each VE trial were averaged and compared with 28 
baseline values collected immediately before VE using repeated-measures two-way 29 
ANOVA. * p<0.05 vs. corresponding value after intra-renal infusion of saline/drug. # 30 





p<0.05 vs. corresponding value before intra-renal infusion of drug. ɸ p<0.05 vs. sham. 31 
MAP, mean arterial blood pressure; HR, heart rate; VE, volume expansion; CPZ, 32 
capsaizepine; RSNA (% of max), renal sympathetic nerve activity normalized to 33 
maximum activity recorded during baroreflex activation during euthanasia. 34 
 35 
 36 
  37 





Table 3. High-pressure baroreflex parameters during intra-renal infusion of saline 38 
in sham and CIH-exposed rats (cohort 1 and cohort 2). 39 
 40 
Parameter Sham CIH p-value Sham      CIH p-value 
RSNA baroreflex  
First cohort Second cohort 
A1 (%) 73±26 104±32* 0.043 114±30 100±22 0.280 
A2 
(mmHg-1) 
0.29±0.27 0.09±0.05* 0.016 0.10±0.03 0.15±0.14 0.912 
A3 (mmHg) 109±6 129±14* 0.005 123±8 121±17 0.757 
A4 (%) 35±20 22±13 0.131 14±13 24±10 0.062 






0.237 2.8±0.9 3.4±2.5 0.739 
Operating 
range (mmHg) 
27±23 53±25* 0.016 44±16 40±18 0.646 
HR baroreflex 
First cohort Second cohort 
A1 (beats/min) 59±25 65±44 0.732 88±31 92±40 0.843 
A2  
(mmHg-1) 
0.16±0.18 0.19±0.19 0.673 0.12±0.08 0.11±0.04 0.674 
A3 (mmHg) 116±9 122±15 0.341 125±17 125±15 0.999 
A4 (beats/min ) 370±46 410±59 0.139 387±38 397±76 0.707 
Max. gain  
(mmHg-1) 
1.8±1.5 2.1±1.5 0.423 2.2±0.8 2.2±0.9 0.821 
 41 
Data are expressed as mean±SD and represent baroreflex parameters of cohort 1 (sham, 42 
n=10; CIH, n=8) and cohort 2 (sham, n=10; CIH, n=10). Datawere analysed using 43 
independent sample t-tests. * p<0.05 vs. sham group. CIH, chronic intermittent hypoxia; 44 
RSNA, renal sympathetic nerve activity; HR, heart rate; A1, response range of 45 
RSNA/HR; A2, the gain coefficient; A3, midpoint pressure of input; A4, the minimum 46 










Table 4: Biomarker concentrations in kidney tissue homogenates of sham and CIH-52 
exposed rats.  53 
 54 
 55 
Data are expressed as mean±SD. AOPP, advanced oxidation protein products; SOD, 56 
superoxide dismutase. SOD activity, keratinocyte chemoattractant/growth related 57 
oncogene and IL-1β concentrations were analysed using independent samples t-test. 58 





Parameter Sham CIH p-value 





































Downloaded from journals.physiology.org/journal/ajprenal at Univ Col Cork (143.239.102.069) on November 19, 2020.
Chronic intermittent hypoxia impairs diuretic and 
natriuretic responses to volume expansion in rats with 
preserved low-pressure baroreflex control of the kidney
OUTCOMEMETHODS
CONCLUSION Exposure to CIH blunts the high-pressure 
but not low-pressure baroreflex control of RSNA, most likely 
indirectly due to hypertension. CIH also impairs diuretic and 
natriuretic responses to fluid overload, which may involve 
intra-renal TRPV1 signaling. F-00377-2020
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